Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
Access Status
Authors
Date
2014Type
Metadata
Show full item recordCitation
Source Title
ISSN
School
Collection
Abstract
© 2014 Elsevier Inc. Recent genomic analyses of pathologically defined tumor types identify 'within-a-tissue' disease subtypes. However, the extent to which genomic signatures are shared across tissues is still unclear. We performed an integrative analysis using five genome-wide platforms and one proteomic platform on 3,527 specimens from 12 cancer types, revealing a unified classification into 11 major subtypes. Five subtypes were nearly identical to their tissue-oforigin counterparts, but several distinct cancer types were found to converge into common subtypes. Lung squamous, head and neck, and a subset of bladder cancers coalesced into one subtype typified by TP53 alterations, TP63 amplifications, and high expression of immune and proliferation pathway genes. Of note, bladder cancers split into three pancancer subtypes. The multiplatform classification, while correlated with tissue-of-origin, provides independent information for predicting clinical outcomes. All data sets are available for data-mining from a unified resource to support further biological discoveries and insights into novel therapeutic strategies.
Related items
Showing items related by title, author, creator and subject.
-
Chen, L.; Yuan, Y.; Kar, S.; Kanchi, M.; Arora, S.; Kim, J.; Koh, P.; Yousef, E.; Samy, R.; Shanmugam, M.; Tan, T.; Shin, S.; Arfuso, Frank; Shen, H.; Yang, H.; Goh, B.; Park, J.; Gaboury, L.; Lobie, P.; Sethi, Gautam; Lim, L.; Kumar, Alan (2017)Metastatic breast cancer is still incurable so far; new specifically targeted and more effective therapies for triple-negative breast cancer (TNBC) are required in the clinic. In this study, our clinical data have established ...
-
Hudson, T.; Anderson, W.; Aretz, A.; Barker, A.; Bell, C.; Bernabé, R.; Bhan, M.; Calvo, F.; Eerola, I.; Gerhard, D.; Guttmacher, A.; Guyer, M.; Hemsley, F.; Jennings, J.; Kerr, D.; Klatt, P.; Kolar, P.; Kusuda, J.; Lane, D.; Laplace, F.; Lu, Y.; Nettekoven, G.; Ozenberger, B.; Peterson, J.; Rao, T.; Remacle, J.; Schafer, A.; Shibata, T.; Stratton, M.; Vockley, J.; Watanabe, K.; Yang, H.; Yuen, M.; Knoppers, B.; Bobrow, M.; Cambon-Thomsen, A.; Dressler, L.; Dyke, S.; Joly, Y.; Kato, K.; Kennedy, K.; Nicolás, P.; Parker, M.; Rial-Sebbag, E.; Romeo-Casabona, C.; Shaw, K.; Wallace, S.; Wiesner, G.; Zeps, Nikolajs; Lichter, P.; Biankin, A.; Chabannon, C.; Chin, L.; Clément, B.; Alava, E.; Degos, F.; Ferguson, M.; Geary, P.; Hayes, D.; Johns, A.; Kasprzyk, A.; Nakagawa, H.; Penny, R.; Piris, M.; Sarin, R.; Scarpa, A.; De Vijver, M.; Futreal, P.; Aburatani, H.; Bayés, M.; Bowtell, D.; Campbel, P.; Estivill, X.; Grimmond, S.; Gut, I.; Hirst, M.; López-Otý´n, C.; Majumder, P.; Marra, M.; McPherson, J.; Ning, Z.; Puente, X.; Ruan, Y.; Stunnenberg, H.; Swerdlow, H.; Velculescu, V. (2010)The International Cancer Genome Consortium (ICGC) was launched to coordinate large-scale cancer genome studies in tumours from 50 different cancer types and/or subtypes that are of clinical and societal importance across ...
-
Chen, L.; Yuan, Y.; Kar, S.; Kanchi, M.; Arora, S.; Kim, J.; Koh, P.; Yousef, E.; Samy, R.; Shanmugam, M.; Tan, T.; Shin, S.; Arfuso, Frank; Shen, H.; Yang, H.; Goh, B.; Park, J.; Gaboury, L.; Lobie, P.; Sethi, G.; Lim, L.; Kumar, Alan Prem (2017)Metastatic breast cancer is still remain incurable so far, new specifically targeted and more effective therapies for triple negative breast cancer (TNBC) are required in the clinic. In this study, our clinical data has ...